Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
HcHAb18
- Development stage
- Unknown
- Lead developer
- Jiangsu Pacific Meinok Biopharmaceutical
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Administration
- Intravenous
01
Overview
HcHAb18 is a humanized monoclonal antibody directed against CD147 (also known as Basigin or EMMPRIN), a cell surface glycoprotein that is highly expressed in many solid tumors, including non-small cell lung cancer (NSCLC). CD147 is involved in promoting tumor cell proliferation, apoptosis resistance, and the induction of matrix metalloproteinases (MMPs) which facilitate extracellular matrix degradation and metastasis. By binding to CD147, HcHAb18 aims to block these oncogenic pathways. The drug was developed by Jiangsu Pacific Meinuoke Biopharmaceutical and has been investigated in early-phase clinical trials for safety and preliminary efficacy in patients with advanced NSCLC.
- Other names
- humanized HAb18 monoclonal antibodyHAb18HAb-18HAb 18
02
Targets
BSG (Basigin)
Beyond the preview
Go deeper on HcHAb18.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HcHAb18.